World mulls next step as US backs IP waiver on vaccines

Activists cheered, Big Pharma complained and government leaders assessed next steps on Thursday after the Biden administration’s blockbuster move to support an easing of patent and other protections on COVID-19 vaccines that many hope will help poorer countries get more doses and speed the end of the pandemic.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *